Janus Henderson Group
CAPR icon

Janus Henderson Group’s Capricor Therapeutics CAPR Stock Holding History

Janus Henderson Group’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$687K Buy
+22,600
New +$602K ﹤0.01% 1860
2025
Q3 		– Sell
-16,400
Closed -$163K – 2413
2025
Q2 		$163K Hold
16,400
– – ﹤0.01% 2357
2025
Q1 		$189K Hold
16,400
– – ﹤0.01% 2374
2024
Q4 		$226K Buy
+16,400
New +$287K ﹤0.01% 2381

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Janus Henderson Group's CAPR Position: Q1 2026 in Review

Janus Henderson Group opened a new position in Capricor Therapeutics (CAPR) in Q1 2026: 22,600 shares worth $687K. The stake represents ﹤0.01% of the portfolio and ranks #1860 among its holdings. This is a return to the name: Janus Henderson Group previously reported a position in CAPR as recently as Q2 2025.

Janus Henderson Group first reported a position in CAPR in Q4 2024 and has held it in 4 quarters since. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Janus Henderson Group held 22,600 shares of Capricor Therapeutics worth $687K as of Q1 2026.
  • Capricor Therapeutics was a new Janus Henderson Group position in Q1 2026.
  • Capricor Therapeutics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1860 holding.
  • Janus Henderson Group first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.